Labor Market Pulse · Life Sciences · September 2026
Life Sciences Labor Market Report: Indianapolis-Carmel, IN MSA — September 2026
Indianapolis regulatory pay lags national market by a third.
Regulatory Affairs Specialist advertised pay fell to a $67,948 metro median against a $104,000 national figure, even as Clinical Research Associate pay climbed to $101,918 locally — a split market demanding function-specific, not blanket, compensation strategy.
Free archive edition. Published by WageScape as sent to subscribers; data as of September 2026.
Key indicators
- Metro unemployment rate: 3.4% — Up from 3.0% in May 2026; Indiana statewide at 3.3%
- Indiana life sci postings YoY: -31% — vs 170+ open roles still reported statewide
- Regulatory Affairs pay gap: $67,948 vs $104,000 — Metro median 35% below national median
- Marion County wage growth: 4.6% YoY — Average weekly wage $1,445, Q3 2025 data
Key takeaways
Regulatory Affairs pay gap looks like a retention liability.
Indianapolis Regulatory Affairs Specialist advertised pay fell to $67,948 even as the national median held near $104,000 and senior regulatory talent commands $320K-$580K nationally amid EU MDR and FDA pathway pressure. A metro lagging this far behind national pricing risks losing regulatory talent to remote or coastal opportunities just as the function becomes strategically critical.
Clinical operations roles are pricing in local scarcity.
Clinical Research Associate advertised pay climbed to a $101,918 metro median, outpacing the $90,956 national figure, while Clinical Data Manager pay reached $125,138 locally against a declining national median. Both signal Indianapolis employers competing hard for clinical execution talent even as broader posting volume contracts.
Manufacturing buildout is absorbing scarce CMC talent early.
Eli Lilly's $13B Lebanon Medicine Foundry and INCOG BioPharma's Fishers expansion are adding roughly 1,400 combined roles ahead of 2027-2030 operational timelines, concentrating demand in quality and production-technician functions years before full ramp-up. Employers competing for this talent now should expect compensation pressure to build well ahead of facility openings, not after.
Falling postings mask selective, not weak, demand.
Indiana life sciences postings dropped 31% year-over-year through August, yet 170+ open roles persist statewide and 64% of surveyed biopharma organizations nationally report active recruiting despite September layoffs. Posting volume alone understates competitive intensity for credentialed scientific and regulatory specialists.
Median advertised pay by role — Indianapolis-Carmel, IN MSA
| Role | 25th percentile | Median advertised pay | 75th percentile | Metro trend | National median |
|---|---|---|---|---|---|
| Research Scientist | $117,796 | $141,635 | $160,000 | Moderate decline | $131,354 |
| Clinical Research Associate | $60,000 | $101,918 | $119,254 | Significant increase | $90,956 |
| Lab Technician | $41,521 | $45,162 | $46,800 | Stable | $47,402 |
| Regulatory Affairs Specialist | $67,649 | $67,948 | $116,076 | Moderate decline | $104,000 |
| Clinical Data Manager | $105,522 | $125,138 | $140,226 | Significant increase | $123,031 |
| Biostatistician | $113,993 | $141,012 | $148,100 | Significant increase | $133,322 |
| Validation Engineer | $86,000 | $94,538 | $106,761 | Moderate decline | $108,377 |
WageScape's median is calibrated to correct for spurious low-value postings (reported as the 60th percentile of raw advertised pay). Download: CSV · JSON
Local market conditions
Indianapolis-Carmel-Anderson unemployment edged up to 3.4% in June from 3.0% in May, even as Marion County average weekly wages rose 4.6% year-over-year to $1,445 — a labor market where modest softening in hiring volume coexists with persistent wage pressure in specialized functions. Statewide life sciences job postings fell 31% year-over-year through August, yet recruiters report 170+ open life sciences roles across Indiana, indicating the contraction is concentrated in volume hiring while credentialed scientific and regulatory talent remains scarce.
What it means
Divergence between falling posting volume and persistent specialty scarcity means headcount planning should differentiate by function rather than apply blanket hiring freezes — Indianapolis Clinical Research Associate pay rose to a $101,918 metro median while Regulatory Affairs Specialist advertised pay fell to $67,948, a gap that may reflect local employers under-pricing regulatory talent just as national VP-level regulatory compensation climbs toward $580K for scarce BLA/NDA expertise. Build-vs-outsource decisions in CMC and manufacturing should account for Eli Lilly's Medicine Foundry and INCOG BioPharma's expansion absorbing local production-technician and quality talent ahead of 2027 ramp-up; organizations should evaluate whether Indianapolis regulatory affairs compensation is positioned to retain talent against a nationally tightening market rather than benchmarking solely against prior-year local postings.
Looking ahead
Early indicator: Watch whether Owens Corning's 130-worker Walkerton layoff and other Indiana manufacturing WARN notices release any transferable quality or process-engineering talent into the life sciences candidate pool over the next quarter.
Potential inflection point: INCOG BioPharma's path toward tripling Fishers headcount by 2030 and Lilly's 2027 Medicine Foundry opening suggest CMC and production-technician compensation pressure should intensify through early 2027 hiring cycles, not wait for facility completion.
Worth watching: Regulatory Affairs Specialist advertised pay sitting roughly 35% below the national median warrants monitoring for attrition signals, particularly as national regulatory director roles shift toward strategic leadership mandates commanding six-figure premiums.
Emerging pressure point: National biopharma layoffs (BioMarin, Bristol Myers) concentrated in consolidation functions rather than execution roles suggest Indianapolis employers may see experienced talent surface locally without easing competition for clinical, quality, or regulatory specialists.
Methodology
Advertised pay from active employer job postings, not survey data. WageScape's median is calibrated to correct for spurious low-value postings: distribution analysis shows roughly the lowest 10% of raw values are erroneous entries, so the reported median is the 60th percentile of raw advertised pay. WageScape observes 98% of U.S. job openings daily.
Free to read and cite with attribution to WageScape. Terms of use.